GUFICBIONSEGufic Biosciences Limited· PharmaceuticalsLowNeutral
Announced Tue, 2 Jun · 15:26 IST

Gufic Biosciences Limited has informed the Exchange about Corrigendum and Clarification to Intimation dated May 29, 2026 regarding Subscription to Shares of Saraswat Co-operative Bank Limited

Strategic Transactions View source PDF

GUFICBIO · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+4.3%1-day move
₹347.00
prior close
₹352.85
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+4.3+1.5+7.3+8.6+10.8+2.3+6.6+10.8
Up moveDown movePending
AI summary

Gufic Biosciences has issued a corrigendum and clarification to its earlier intimation dated May 29, 2026, which was about subscribing to shares of Saraswat Co-operative Bank Limited. A corrigendum is a correction or additional information issued to fix or clarify details in a previously filed announcement. The underlying transaction itself appears unchanged — Gufic is investing in shares of Saraswat Co-operative Bank, a co-operative banking institution. No new financial figures, deal value, or change in direction have been introduced in this update.

Likely market impact

This is an administrative correction to a previously disclosed investment and is unlikely to have any material impact on the stock price or shareholder value. Investors should look at the original May 29, 2026 intimation for the actual details of the subscription.